Munich, Germany

Anja Huste

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Theravance Biopharma R&d IP, LLC. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Anja Huste: Innovator in Pharmaceutical Processes

Introduction

Anja Huste is a prominent inventor based in Munich, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative processes for drug preparation. Her work is characterized by a focus on creating effective treatments through advanced chemical methodologies.

Latest Patents

Anja Huste holds a patent for "Processes for preparing a pan-JAK inhibitor and related intermediate compounds." This patent outlines processes for preparing a crystalline form of a specific compound, which is crucial for the development of new therapeutic agents. The compound in question is 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile and its related intermediate compounds.

Career Highlights

Anja is currently employed at Theravance Biopharma R&D IP, LLC, where she continues to push the boundaries of pharmaceutical research. Her innovative approach has led to the successful development of new processes that enhance the efficiency and effectiveness of drug formulation.

Collaborations

Anja collaborates with talented professionals in her field, including Vit Lellek and Dimitar Filipov. These partnerships foster a dynamic environment for innovation and contribute to the advancement of pharmaceutical sciences.

Conclusion

Anja Huste is a remarkable inventor whose work in pharmaceutical processes exemplifies the impact of innovation in healthcare. Her contributions are paving the way for new treatments and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…